Welcome to our dedicated page for Lensar SEC filings (Ticker: LNSR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
LENSAR, Inc. filings document operating results and material events for a commercial-stage medical device company focused on robotic laser systems for cataract procedures. Form 8-K reports furnish quarterly and annual earnings releases, including disclosures on ALLY system activity, installed-base trends, and recurring revenue components such as procedure, lease, and service revenue.
The company’s filings also record capital and governance matters, including common stock listed on Nasdaq under LNSR, officer transition disclosures, and material agreements such as the Priority Credit Line Agreement. Amendments to material-event reports provide additional detail on credit-line terms, collateral arrangements, interest-rate mechanics, and default provisions.
LENSAR, Inc. director and 10% owner Todd B. Hammer received a grant of 17,421 restricted stock units as part of his annual non-employee director compensation. Each RSU converts into one share of common stock and vests in full on June 3, 2027, contingent on his continued service or earlier specified events. Following this grant, Hammer directly holds 56,083 common shares. Separately, 1,100,592 common shares are reported as held by North Run Capital, LP and may be deemed indirectly owned by North Run Advisors, LLC and Hammer, who disclaims beneficial ownership except to the extent of his pecuniary interest.
ELLIS THOMAS B reported acquisition or exercise transactions in this Form 4 filing.
LENSAR, Inc. director and greater-than-10% holder Thomas B. Ellis reported an equity award and updated holdings. He received 17,421 restricted stock units, each representing one share of common stock, granted at no cash cost as part of his annual non-employee director compensation.
The RSUs vest in full on June 3, 2027, if he continues serving the company, or earlier upon termination of service, a change in control, death, or disability. After this grant, he directly holds 56,083 common shares. Separately, 1,100,592 common shares are reported as indirectly held through North Run Capital, LP and North Run Advisors, LLC, with Ellis disclaiming beneficial ownership beyond his pecuniary interest.
Wong Kendra reported acquisition or exercise transactions in this Form 4 filing.
LENSAR, Inc. reported that Principal Accounting Officer Kendra Wong received a grant of 13,066 restricted stock units (RSUs) of common stock. Each RSU represents the right to receive one share of LENSAR common stock if vesting conditions are met.
The RSUs vest in four substantially equal annual installments on each anniversary of the grant date, as long as Wong continues to provide service to the company through each vesting date. After this award, she directly holds 56,481 shares of LENSAR common stock.
Connaughton Alan B. reported acquisition or exercise transactions in this Form 4 filing.
LENSAR, Inc. reported that Chief Operating Officer Alan B. Connaughton received a grant of 34,843 shares of common stock on June 3, 2026 in the form of restricted stock units (RSUs) at no cash cost. Each RSU represents one share of common stock and vests in four substantially equal annual installments on each anniversary of the grant date, subject to his continued service. Following this award, Connaughton directly holds a total of 389,173 shares, including the RSUs, reflecting a routine compensation-related equity grant rather than an open-market purchase or sale.
CURTIS NICHOLAS T reported acquisition or exercise transactions in this Form 4 filing.
LENSAR, Inc. reported that Chief Executive Officer Nicholas T. Curtis received a grant of 130,662 restricted stock units (RSUs) of common stock at no purchase price. Each RSU represents the right to receive one share of LENSAR common stock.
The RSUs vest in four substantially equal annual installments on each anniversary of the grant date, as long as he continues serving the company through each vesting date. After this award, Curtis directly holds 1,122,758 shares of LENSAR common stock.
WEISNER AIMEE S reported acquisition or exercise transactions in this Form 4 filing.
LENSAR, Inc. director Aimee S. Weisner received a grant of 17,421 restricted stock units (RSUs) of common stock as part of her annual non-employee director compensation. The award was granted at no cash cost per unit and is structured as equity-based compensation rather than an open-market purchase.
Each RSU represents the right to receive one share of LENSAR common stock, vesting in full on June 3, 2027, provided she continues serving the company through that date. The RSUs may also settle earlier upon her termination of service, a change in control of the company, or her death or disability. Following this grant, she is reported to own 110,368 shares directly.
O'Farrell Elizabeth G. reported acquisition or exercise transactions in this Form 4 filing.
LENSAR, Inc. director Elizabeth G. O'Farrell received an equity grant of 17,421 restricted stock units of common stock as part of her annual non-employee director compensation. Each RSU represents one share of common stock and vests in full on June 3, 2027, subject to her continued service to the company.
The RSUs will be settled upon the earliest of her termination of service, a change in control of the company, or her death or disability. Following this grant, she holds 67,368 shares of common stock directly.
Winer Gary M reported acquisition or exercise transactions in this Form 4 filing.
LENSAR, Inc. director Gary M. Winer received an equity award of 17,421 restricted stock units, each representing one share of common stock. These RSUs vest in full on June 3, 2027, subject to his continued service, and bring his direct holdings to 105,635 shares. The award was granted as part of the company’s non-employee director compensation program and will be settled upon vesting or earlier upon certain events such as a change in control, death, disability, or termination of service.
LINDSTROM RICHARD L MD reported acquisition or exercise transactions in this Form 4 filing.
LENSAR, Inc. reported that director Richard L. Lindstrom, MD received a grant of 17,421 restricted stock units (RSUs) of common stock as part of his annual non-employee director compensation. Each RSU represents one share of common stock and was granted at no cash purchase price.
The RSUs vest in full on June 3, 2027, if he continues to provide service to the company through that date. They will be settled in shares upon the earliest of his service termination, a change in control of the company, or his death or disability. Following this award, he holds 263,831 shares directly.
LINK WILLIAM J PHD reported acquisition or exercise transactions in this Form 4 filing.
LENSAR, Inc. director William J. Link, Ph.D. received a grant of 17,421 restricted stock units (RSUs) of common stock on June 3, 2026 as part of his annual non-employee director compensation. Each RSU represents a contingent right to one share of common stock and will vest in full on June 3, 2027, if he continues serving the company through that date. The RSUs will be settled in shares upon the earliest of his termination of service, a change in control of the company, or his death or disability. Following this grant, his direct holdings reported in this filing total 568,062 shares and RSUs.